Skip to main content
. 2021 Oct 18;20:210. doi: 10.1186/s12933-021-01401-8

Fig. 1.

Fig. 1

Forest plot of risk (HR, hazard ratio) of MACE (major cardiovascular events) with the use of DPP-4i, GLP-1RA or SGLT-2i, as compared with placebo, in patients with type 2 diabetes participating in 18 CVOTs (cardiovascular outcome trials)